| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $52.0M | -18.5% |
| Cost of Revenue | $6.6M | +16.9% |
| R&D Expense | $197.1M | +54.4% |
| SG&A Expense | $64.4M | +6.1% |
| Operating Income | -$270.0M | -57.2% |
| Interest Expense | $887K | +0.0% |
| Income Tax | $0 | — |
| Net Income | -$265.9M | -37.4% |
| EPS (Basic) | -$1.42 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $737.1M | +88.0% |
| Accounts Receivable | $30.6M | -5.4% |
| Inventory | $3.6M | +17.2% |
| Current Assets | $782.1M | +77.4% |
| Total Assets | $808.1M | +76.5% |
| Current Liabilities | $50.8M | +22.9% |
| Total Liabilities | $153.7M | +7.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$204.9M | -52.1% |
| Capital Expenditures | $12.0M | +832.5% |
| Investing Cash Flow | -$11.9M | -822.4% |
| Financing Cash Flow | $561.7M | +69.1% |
| Free Cash Flow | -$216.9M | -59.5% |
| -16.4% |
| EPS (Diluted) | -$1.42 | -16.4% |
| Stockholders' Equity |
| $654.3M |
| +107.5% |